tradingkey.logo
搜索

PolyPid Ltd

PYPD
添加自选
4.290USD
-0.080-1.83%
收盘 07-31 16:00美东报价延迟15分钟
78.10M总市值
亏损市盈率 TTM

关于 PolyPid Ltd 公司

Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

PolyPid Ltd简介

公司代码PYPD
公司名称PolyPid Ltd
上市日期Jun 26, 2020
CEOAkselbrad (Dikla Czaczkes)
员工数量57
证券类型Ordinary Share
年结日Jun 26
公司地址18 Hasivim Street, P.O Box 7126
城市PETAH TIKVA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Israel
邮编4917002
电话972747195700
网址https://www.polypid.com
公司代码PYPD
上市日期Jun 26, 2020
CEOAkselbrad (Dikla Czaczkes)

PolyPid Ltd公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
--
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Dr. Noam Emanuel, Ph.D.
Dr. Noam Emanuel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mrs. Anat Tsour Segal
Mrs. Anat Tsour Segal
Independent Director
Independent Director
--
--
Dr. Shaul Mukhtar, Ph.D.
Dr. Shaul Mukhtar, Ph.D.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
Ms. Dalit Hazan
Ms. Dalit Hazan
Senior Vice President - Research and Development and Regulatory Affairs
Senior Vice President - Research and Development and Regulatory Affairs
--
--
Mr. Nir Dror
Mr. Nir Dror
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
--
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Dr. Noam Emanuel, Ph.D.
Dr. Noam Emanuel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--

常见问题

PolyPid Ltd的前五大股东是谁?

PolyPid Ltd 的前五大股东如下:Dr. Yechezkel Barenholz, Ph.D.

有多少机构持有PolyPid Ltd(PYPD)的股份?

截至2026Q1,共有33家机构持有PolyPid Ltd的股份,合计持有的股份价值约为6.41M,占公司总股份的33.61%。与2025Q4相比,机构持股有所增加,增幅为15623.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有